SE433304B - Farmaceutiska preparat med terapeutiska, speciellt anti- androgena och schistosomicida egenskaper - Google Patents

Farmaceutiska preparat med terapeutiska, speciellt anti- androgena och schistosomicida egenskaper

Info

Publication number
SE433304B
SE433304B SE7811193A SE7811193A SE433304B SE 433304 B SE433304 B SE 433304B SE 7811193 A SE7811193 A SE 7811193A SE 7811193 A SE7811193 A SE 7811193A SE 433304 B SE433304 B SE 433304B
Authority
SE
Sweden
Prior art keywords
schistosomicid
androgen
therapeutic
properties
pharmaceutical preparations
Prior art date
Application number
SE7811193A
Other languages
English (en)
Swedish (sv)
Other versions
SE7811193L (sv
Inventor
K Bernauer
H Link
H Stohler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH546678A external-priority patent/CH639846A5/de
Priority claimed from CH546578A external-priority patent/CH642944A5/de
Priority claimed from CH940778A external-priority patent/CH644850A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7811193L publication Critical patent/SE7811193L/xx
Publication of SE433304B publication Critical patent/SE433304B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SE7811193A 1977-10-28 1978-10-27 Farmaceutiska preparat med terapeutiska, speciellt anti- androgena och schistosomicida egenskaper SE433304B (sv)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
LU78407 1977-10-28
LU78408 1977-10-28
CH546678A CH639846A5 (en) 1978-05-19 1978-05-19 Pharmaceutical preparations having antiandrogenic action, containing urea derivatives or hydantoin derivatives
CH546578A CH642944A5 (en) 1978-05-19 1978-05-19 Urea derivatives
CH940778A CH644850A5 (en) 1977-10-28 1978-09-07 Pharmaceutical preparations containing urea derivatives

Publications (2)

Publication Number Publication Date
SE7811193L SE7811193L (sv) 1979-04-29
SE433304B true SE433304B (sv) 1984-05-21

Family

ID=27509239

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7811193A SE433304B (sv) 1977-10-28 1978-10-27 Farmaceutiska preparat med terapeutiska, speciellt anti- androgena och schistosomicida egenskaper
SE8202106A SE8202106L (sv) 1977-10-28 1982-04-01 Karbamidderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8202106A SE8202106L (sv) 1977-10-28 1982-04-01 Karbamidderivat

Country Status (15)

Country Link
US (1) US4234736A (fr)
JP (1) JPS5473754A (fr)
AU (2) AU522796B2 (fr)
BE (1) BE871584A (fr)
BR (1) BR7807115A (fr)
CA (2) CA1138334A (fr)
DE (1) DE2846945A1 (fr)
DK (1) DK481778A (fr)
FR (1) FR2407205A1 (fr)
GB (2) GB2008101B (fr)
IL (1) IL55774A (fr)
IT (1) IT1100904B (fr)
NL (1) NL7810562A (fr)
NZ (1) NZ188720A (fr)
SE (2) SE433304B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
FI801184A7 (fi) * 1979-04-24 1981-01-01 F Hoffmann La Roche & Co Menetelmä imidatsolidiini-johdannaisten valmistamiseksi.
DE3382406D1 (de) * 1982-04-08 1991-10-17 Shell Int Research Neue hydantoine, ihre herstellung und verwendung.
WO1990002112A1 (fr) * 1988-08-23 1990-03-08 The Nutrasweet Company Arylurees substituees utilisees comme edulcorants de forte puissance
FR2656302B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveau procede de preparation de l'anandron et derives de l'anandron.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2671348B1 (fr) * 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US5670641A (en) * 1995-06-02 1997-09-23 American Cyanamid Company 3-(3-aryloxyphenyl)-1-(substituted methyl)-S-triazine-2,4,6-oxo or thiotrione herbicidal agents
US7001911B2 (en) * 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
JP2004509072A (ja) * 2000-06-28 2004-03-25 ブリストル−マイヤーズ　スクイブ　カンパニー 選択的アンドロゲン受容体モジュレーター並びにその同定、設計及び使用方法
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (fr) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Composés de succinimide hétérocyclique fondu et leurs analogies, modulateurs de la fonction de récepteur d'hormone nucléaire
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
AU2002364082A1 (en) 2001-12-19 2003-07-09 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
EP1709193B1 (fr) * 2003-12-19 2011-03-16 The Regents of The University of California Procedes et materiaux pour evaluer des therapies du cancer de la prostate
WO2005099693A2 (fr) * 2004-02-24 2005-10-27 The Regents Of The University Of California Methodes et substances permettant d'evaluer des therapies du cancer de la prostate, et composes s'y rapportant
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
ES2689292T3 (es) 2006-03-27 2018-11-13 The Regents Of The University Of California Modulador del receptor de andrógenos para el tratamiento del cáncer de próstata y enfermedades asociadas con el receptor de andrógenos
NZ572374A (en) 2006-03-29 2011-12-22 Univ California Diarylthiohydantoin compounds
EP2220050A2 (fr) 2007-10-26 2010-08-25 The Regents Of The University Of California Composés de diarylhydantoïne
SG10201907588XA (en) 2010-02-16 2019-09-27 Aragon Pharmaceuticals Inc Androgen Receptor Modulators And Uses Thereof
CN115737643A (zh) 2012-09-26 2023-03-07 阿拉贡药品公司 用于治疗非转移性去势抵抗性前列腺癌的抗雄激素
DK2945628T3 (da) 2013-01-15 2020-05-04 Aragon Pharmaceuticals Inc Androgen receptormodulator i kombination med abirateronacetat og prednison til behandling af prostatacancer
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
MX2020003845A (es) 2017-10-16 2020-11-06 Aragon Pharmaceuticals Inc Antiandrógenos para el tratamiento de cáncer de próstata no metastásico resistente a la castración.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629779A (fr) *
US3134663A (en) * 1957-07-23 1964-05-26 Geigy Chem Corp Herbicidal composition and method employing hydantoins
GB997037A (en) 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
IL31416A0 (en) 1968-02-19 1969-03-27 Bayer Ag 5-imino-2-oxo-imidazolidines,their preparation and use as herbicides
NO124370B (fr) * 1968-03-28 1972-04-10 Ciba Geigy Ag
DK123717B (da) * 1968-11-25 1972-07-24 Sumitomo Chemical Co 3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning.
US3676456A (en) * 1970-02-27 1972-07-11 Ciba Geigy Corp Derivatives of 3-aryl-5-alkylhydantoins
JPS5136332B1 (fr) * 1970-12-09 1976-10-07
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
IL45459A (en) 1973-09-03 1978-01-31 Ciba Geigy Ag 1-(dichlorofluoromethylthio)-3-phenyl-imidazolidine-2,4-dione derivatives their preparation and their use as bactericides and fungicides
FR2329276A1 (fr) 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant

Also Published As

Publication number Publication date
GB2008101A (en) 1979-05-31
AU522796B2 (en) 1982-06-24
FR2407205A1 (fr) 1979-05-25
DK481778A (da) 1979-04-29
CA1138334A (fr) 1982-12-28
AU8105182A (en) 1982-07-08
GB2087870A (en) 1982-06-03
IL55774A (en) 1982-04-30
FR2407205B1 (fr) 1982-12-31
AU551161B2 (en) 1986-04-17
US4234736A (en) 1980-11-18
JPS5473754A (en) 1979-06-13
BE871584A (fr) 1979-04-27
SE8202106L (sv) 1982-04-01
DE2846945A1 (de) 1979-05-03
IT1100904B (it) 1985-09-28
CA1137091A (fr) 1982-12-07
GB2087870B (en) 1982-11-10
GB2008101B (en) 1982-09-08
IT7829207A0 (it) 1978-10-27
NZ188720A (en) 1984-12-14
IL55774A0 (en) 1978-12-17
BR7807115A (pt) 1979-05-15
AU4096278A (en) 1980-05-01
NL7810562A (nl) 1979-05-02
SE7811193L (sv) 1979-04-29

Similar Documents

Publication Publication Date Title
FI801876A7 (fi) Farmaceutiska preparat
IT7823672A0 (it) Derivati di idantoina ad azione terapeutica e relativo procedimento di preparazione.
DK377678A (da) 3,4,5-trihydroxypiperidinderivater deres fremstilling og anvendelse
SE7803848L (sv) Cykloalkan-substituerade fenylettiksyraderivat, deras anvendning och framstellning
SE7810893L (sv) Alkanoylprolin-derivat och homologer derav, deras framstellning och anvendning
IT1148801B (it) Derivati del nor-tropano, loro procedimento di preparazione e loro applicazione terapeutica
SE7910354L (sv) Medicinskt preparat
BE871584A (fr) Preparations pharmaceutiques
BE849196A (fr) Derives de l'argininamide, leur preparation et leurs utilisation therapeutiques
IT1094434B (it) Cinnamoil piperazione e cinnamoil omopiperazione,procedimento per la loro preparazione e loro applicazione in terapia
IT1095356B (it) Oligopeptidi trifluorometilati,procedimento per la loro preparazione e loro applicazione terapeutica
SE7807753L (sv) Organiska foreningar, deras framstellning och anvendning
SE8003485L (sv) Pyrazinobensodiazepiner, deras framstellning och anvendning
NL7809626A (nl) Therapeutische preparaat.
CH611768A5 (en) Ground-hugging harrow, especially for the upkeep of meadows and pastures
FI802690A7 (fi) Dermatologiskt laekemedel
IT1115363B (it) Amminoalcossibenzofurani,loro procedimento di preparazione e loro applicazione in terapia
SE7801074L (sv) Organiska foreningar, deras framstellning och anvendning
DK144333C (da) Thioamider med insecticide,acaricide og tickicide egenskaber
SE7713243L (sv) Substituerade aminoetanoler, deras framstellning och farmaceutiska anvendning
DK333476A (da) 2-chlor-n-isopropyl-2',3'-dimethylacetanilid samt dets fremstilling og anvendelse
SE7811593L (sv) 2,4-diamino-5-bensylpyrimidiner och forfarande for framstellning derav
FI803221L (fi) Terapeutiskt anvaendbara pyridinderivat
IT8021641A0 (it) Alogeno-derivati della isopropilamminopirimidina, loro preparazione e impiego terapeutico.
FR2316292A1 (fr) Colorants disazoiques, leur obtention et leur application

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7811193-7

Effective date: 19880627

Format of ref document f/p: F